Goldman Sachs Research Summary (JAN 5, 2007)

Posted: January 5, 2007 at 8:09 am

Goldman Sachs full research note summary:
Pfizer (PFE) reinstated as Buy with $30 target.
WellPoint (WLP) raised to Buy from Neutral, but Aetna (AET) cut to Neutral from Buy.
Current fiscal estimates hiked on ACE, AHL, HCC, CB, PTP, RNR, XL by 1% to 2%.  Current fiscal estimates trimmed slightly on Chicos FAS (CHS) and Dow Chemical (DOW).
Atmos Energy (ATO) started as Neutral.

Read more: Analyst Calls
    		•